BRPI0909028A2 - nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos - Google Patents

nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos

Info

Publication number
BRPI0909028A2
BRPI0909028A2 BRPI0909028A BRPI0909028A BRPI0909028A2 BR PI0909028 A2 BRPI0909028 A2 BR PI0909028A2 BR PI0909028 A BRPI0909028 A BR PI0909028A BR PI0909028 A BRPI0909028 A BR PI0909028A BR PI0909028 A2 BRPI0909028 A2 BR PI0909028A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
substituted phenyl
covalently linked
linked bicyclic
phenyl oxazolidinones
Prior art date
Application number
BRPI0909028A
Other languages
English (en)
Inventor
Adrian Blaser
Andrew M Thompson
Brian Desmond Palmer
Charles Z Ding
Dianjun D Chen
Genliang Lu
Hamish Scott Sutherland
Iveta Kmentova
Jiancheng Wang
Keith Combrink
Minsoo Song
William Alexander Denny
Zhenkun Ma
Original Assignee
Global Alliance For Tb Drug Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Alliance For Tb Drug Dev filed Critical Global Alliance For Tb Drug Dev
Publication of BRPI0909028A2 publication Critical patent/BRPI0909028A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0909028A 2008-03-26 2009-03-25 nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos BRPI0909028A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7085508P 2008-03-26 2008-03-26
PCT/US2009/038266 WO2009120789A1 (en) 2008-03-26 2009-03-25 Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones

Publications (1)

Publication Number Publication Date
BRPI0909028A2 true BRPI0909028A2 (pt) 2015-09-22

Family

ID=40821727

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909028A BRPI0909028A2 (pt) 2008-03-26 2009-03-25 nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos

Country Status (11)

Country Link
US (1) US7666864B2 (pt)
EP (1) EP2254892B1 (pt)
JP (1) JP5613656B2 (pt)
CN (1) CN101965353B (pt)
AU (1) AU2009228293B2 (pt)
BR (1) BRPI0909028A2 (pt)
CA (1) CA2712613C (pt)
NZ (1) NZ587096A (pt)
RU (1) RU2504547C2 (pt)
WO (1) WO2009120789A1 (pt)
ZA (1) ZA201006824B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2530266T3 (es) * 2009-07-31 2015-02-27 Global Alliance For Tb Drug Development Análogos de nitroimidazooxazina y sus usos
US9198913B2 (en) 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
NZ598121A (en) * 2009-07-31 2013-04-26 Global Alliance For Tb Drug Dev Nitroimidazooxazines and their uses in anti-tubercular therapy
CN102234287B (zh) * 2010-04-26 2015-08-05 上海阳帆医药科技有限公司 硝基咪唑类化合物、其制备方法和用途
EA021698B1 (ru) 2010-04-27 2015-08-31 Такеда Фармасьютикал Компани Лимитед Производные бициклических соединений и их применение в качестве ингибиторов acc
GB201012209D0 (en) * 2010-05-31 2010-09-08 Ge Healthcare Ltd In vivo imaging agent
WO2012033952A1 (en) 2010-09-10 2012-03-15 Micurx Pharmaceuticals, Inc. 3 - phenyl- 2 -oxo- 1, 3 -oxazolidines for treatment of bacterial infections
EP2616441B1 (en) * 2010-09-17 2019-08-07 Purdue Pharma L.P. Pyridine compounds and the uses thereof
CN103596960B (zh) * 2011-04-15 2016-11-16 大塚制药株式会社 6,7-二氢咪唑并[2,1-b][1,3]噁嗪杀菌剂
WO2013044845A1 (zh) 2011-09-29 2013-04-04 山东轩竹医药科技有限公司 联芳基杂环取代的噁唑烷酮抗菌药
WO2013072903A1 (en) 2011-11-17 2013-05-23 Ithemba Pharmaceuticals (Proprietary) Limited Nitroimidazoxadiazocine compounds
KR101650716B1 (ko) * 2012-11-22 2016-08-24 한국화학연구원 바이시클릭니트로이미다졸 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 결핵의 예방 또는 치료용 약학적 조성물
IN2013DE02954A (pt) * 2013-10-04 2015-04-10 Council Scient Ind Res
KR101564425B1 (ko) 2013-11-26 2015-10-30 한국화학연구원 신규한 바이사이클릭 니트로이미다졸 카바메이트 화합물, 이를 제조하는 방법 및 이를 유효성분으로 함유하는 결핵 질환의 예방 또는 치료용 약제학적 조성물
CN104725330B (zh) * 2013-12-18 2017-06-13 四川好医生药业集团有限公司 噁唑烷酮类化合物及其制备方法和用途
CN104496979A (zh) * 2014-09-17 2015-04-08 博瑞生物医药技术(苏州)有限公司 一种噁唑烷酮类化合物及其中间体的制备方法
KR101682356B1 (ko) 2014-11-04 2016-12-06 한국화학연구원 이미다조 옥사진 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학이성질체 및 이를 유효성분으로 함유하는 약제학적 조성물
CN105732659B (zh) * 2014-12-12 2019-07-16 上海阳帆医药科技有限公司 硝基咪唑类化合物及其制备方法和在制药中的用途
MX2017009810A (es) 2015-01-29 2018-11-09 Medshine Discovery Inc Derivado de nitroimidazol contra tuberculosis pulmonar.
CN106317072B (zh) * 2015-06-17 2020-03-17 盟科医药技术(上海)有限公司 用于分枝杆菌感染治疗的杂环化合物及其应用
BR112017028318B1 (pt) 2015-07-02 2024-02-20 Janssen Sciences Ireland Uc Composto antibacteriano, seu uso, processo para sua preparação,produto que o contém, composição farmacêutica e combinação
WO2017015106A1 (en) * 2015-07-17 2017-01-26 The Global Alliance For Tb Drug Development, Inc. Substituted phenyloxazolidinones for antimicrobial therapy
EP3472158A1 (en) 2016-06-16 2019-04-24 Janssen Sciences Ireland Unlimited Company Heterocyclic compounds as antibacterials
EP3589323B1 (en) 2017-03-01 2024-04-03 Janssen Sciences Ireland Unlimited Company Combination therapy for the treatment of tuberculosis
CN107827927B (zh) * 2017-09-05 2019-08-09 陕西思尔生物科技有限公司 一种镍催化合成磷酸泰地唑利的方法
CN108047248A (zh) * 2018-02-12 2018-05-18 丹诺医药(苏州）有限公司 噁唑烷酮-硝基咪唑类偶联分子的应用
CN111606900A (zh) * 2019-02-24 2020-09-01 陕西合成药业股份有限公司 一种抗感染药物及其制备方法和应用
CN112300192B (zh) * 2019-08-02 2023-08-11 南京长澳医药科技有限公司 硝基咪唑类化合物及其制备方法和用途
CN113527331B (zh) * 2020-04-17 2024-05-28 南京长澳医药科技有限公司 硝基咪唑类衍生物及其制备方法和用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921869A (en) 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1317594C (en) 1987-10-21 1993-05-11 Chung-Ho Park Aminomethyloxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
NZ295528A (en) * 1994-11-15 1999-03-29 Upjohn Co Bicyclic oxazine and thiazine oxazolidinone antibacterials
US5668127A (en) * 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
US6087358A (en) 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
MY116093A (en) 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
AR041198A1 (es) * 2002-10-11 2005-05-04 Otsuka Pharma Co Ltd Compuesto 2,3-dihidro-6-nitroimidazo[2,1-b] oxaxol, y composiciones farmaceuticas que lo contienen
US6962262B2 (en) 2003-02-10 2005-11-08 Dennis Toma Connecting corner for knock down racks
TW200500360A (en) 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
KR101101982B1 (ko) 2003-04-30 2012-01-02 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 옥사졸리디논-퀴놀린 하이브리드 항생제의 탄저병 및 기타감염증의 치료용의 용도
US7687627B2 (en) 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
ATE410430T1 (de) 2003-10-31 2008-10-15 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
TW200526649A (en) 2003-12-17 2005-08-16 Rib X Pharmaceuticals Inc Halogenated biaryl heterocyclic compounds and methods of making and using the same
ATE401326T1 (de) * 2003-12-18 2008-08-15 Morphochem Ag Komb Chemie Oxazolidinon-chinolon hybrid antibiotika
JP4787529B2 (ja) * 2004-04-09 2011-10-05 大塚製薬株式会社 医薬組成物
JP2008508271A (ja) 2004-07-28 2008-03-21 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリール複素環式化合物ならびにその化合物を製造および使用する方法
EP1799677A1 (en) 2004-10-08 2007-06-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2006043121A1 (en) * 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
US20080275035A1 (en) * 2005-12-23 2008-11-06 Jan Jiricek Nitroimidazole Compounds

Also Published As

Publication number Publication date
US7666864B2 (en) 2010-02-23
AU2009228293B2 (en) 2012-11-08
CN101965353B (zh) 2014-12-17
CA2712613A1 (en) 2009-10-01
ZA201006824B (en) 2011-06-29
CA2712613C (en) 2017-02-28
NZ587096A (en) 2011-11-25
JP5613656B2 (ja) 2014-10-29
JP2011515487A (ja) 2011-05-19
AU2009228293A1 (en) 2009-10-01
EP2254892B1 (en) 2014-04-23
US20090281088A1 (en) 2009-11-12
RU2010143541A (ru) 2012-05-10
WO2009120789A8 (en) 2010-10-28
WO2009120789A1 (en) 2009-10-01
EP2254892A1 (en) 2010-12-01
RU2504547C2 (ru) 2014-01-20
CN101965353A (zh) 2011-02-02

Similar Documents

Publication Publication Date Title
BRPI0909028A2 (pt) nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos
LTPA2018014I1 (lt) Farmacinė kompozicija 514
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
SMT201600259B (it) Composizioni farmaceutiche antibatteriche
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
BR112013016772A2 (pt) composto, uso do composto, composição farmacêutica, oligonucleotídeo e conjugado
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
BR112013015397A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0918502A2 (pt) aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0917001A2 (pt) composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
DK2285357T3 (da) Farmaceutisk sammensætning omfattende brivaracetam
BRPI0921654A2 (pt) formulação farmacêutica
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
EP2236149A4 (en) MEDICAL COMPOSITION
BRPI0921935A2 (pt) composições adesivas de uso médico

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: TENNOR THERAPEUTICS LIMITED (CN)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]